Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies

Key facts

Sponsor

TaiwanJ Pharmaceuticals Co., Ltd

Principal Investigator

Ying-Chu Shih, PhD

TaiwanJ Pharmaceuticals

Intervention

JKB-122(drug)

Enrollment

20 enrolled

Eligibility

18 years · All sexes

Timeline

2016 – 2019

Study locations (16)

• Ruane Clinical Research Group, Inc., Los Angeles, California, United States
• University of California Davis Medical Center - Ticon 1, Sacramento, California, United States
• California Pacific Medical Center, San Francisco, California, United States
• University of Florida Hepatology Research at CTRB, Gainesville, Florida, United States
• Northwestern University, Chicago, Illinois, United States
• Indiana University School of Medicine, Indianapolis, Indiana, United States
• Tulane University, New Orleans, Louisiana, United States
• Massachusetts General Hospital, Boston, Massachusetts, United States
• Mount Sinai Hospital, New York, New York, United States
• Duke University Medical Center, Durham, North Carolina, United States
• Methodist Dallas Medical Center, Dallas, Texas, United States
• Advanced Liver Therapies, Baylor College of Medicine, Houston, Texas, United States
• The Texas Liver Institute, San Antonio, Texas, United States
• Taxes Liver Institute, San Antonio, Texas, United States
• Swedish Medical Center - Organ Transplant and Liver Center, Seattle, Washington, United States
• +1 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autoimmune hepatitis

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNCT07378202
  Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis
  Hannover Medical School
• RECRUITINGPHASE2NCT06381453
  Belimumab in Autoimmune Hepatitis
  University Health Network, Toronto
• RECRUITINGPHASE1NCT06455280
  A Study of SIPLIZUMAB in AILD and LT Patients
  Elizabeth C. Verna
• ENROLLING BY INVITATIONNCT06061341
  TruGraf Liver Gene Expression Serial Test
  Washington University School of Medicine
• RECRUITINGNCT06519162
  Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
  Chungnam National University Hospital
• RECRUITINGNANCT06250309
  Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
  Indiana University
• RECRUITINGNCT05810480
  PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
  Hannover Medical School
• RECRUITINGNCT06078098
  Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
  University of Milano Bicocca

See all trials for Autoimmune hepatitis →